WEE1 and neoplasm: We have provided an overview of the challenges in delivering kinase-focused precision medicine intervention strategies for patients in the clinic, including identification of novel kinase oncogenic drivers, emergence of resistance to protein kinase inhibitors, and understanding the contribution of protein kinases to the tumor-microenvironment.